Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model. - Wikidata - wikimedia - TriplyDB

Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.

Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.

http://www.wikidata.org/entity/Q37178190

about

OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.Secreted β3-integrin enhances natural killer cell activity against acute myeloid leukemia cells.Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.Intraperitoneal immunotherapy: historical perspectives and modern therapy.Modeling Natural Killer Cell Targeted Immunotherapies.Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice.Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer.Sestrin2 and sestrin3 suppress NK-92 cell-mediated cytotoxic activity on ovarian cancer cells through AMPK and mTORC1 signaling.Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells.PD-L1 blockade enhances anti-tumor efficacy of NK cells Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis

P2860

Q33749684-989E45FE-B649-4857-9FFD-70A92C2AE316 Q35185573-4CD332B5-D60B-44B6-A409-8C564FDE10F6 Q35623804-1028F410-75D8-47FD-8440-BF79BBCD80C9 Q36463830-20402820-EB52-4E2D-9403-797964C79243 Q36916476-F2048A07-DB5D-43DA-972C-CE87EFF79A74 Q38714915-6FD36C46-A0C0-4A08-A11E-32A1A49A0D81 Q38857163-525D19F2-53C2-4AA9-9C96-95AC7266C93A Q38941698-F3EBCC59-FF70-48ED-9A54-A5CB452F479A Q39005211-D62B614F-8DBD-4E6C-81B7-A1A55F9F6D54 Q39239278-72DF5291-E7D8-49A8-9668-2C92FD7409A1 Q41337940-FAEEF585-70E5-4C2C-B0E4-A58322CFAD2D Q41812231-2E0D0B1E-832C-4AE3-9391-8FA1A276A381 Q46677873-354171CB-4A7C-42C5-AA2A-FDE7E09CBE3C Q47113878-57ECD75A-23D8-4774-A27A-32628DB53803 Q47752280-FC492011-4F9D-4BBC-801B-55C408C3A822 Q58129516-42397F17-442E-4211-804F-5D3D5B45528B Q58582595-ED8563BB-D987-41A1-ACD3-FDB4322042F4 Q58788761-2C5554EE-0CC9-48D5-BF15-8841A24B50F9

P2860

Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.

http://www.wikidata.org/entity/Q37178190

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intraperitoneal delivery of hu ...... er in a mouse xenograft model.

@en

Intraperitoneal delivery of hu ...... er in a mouse xenograft model.

@nl

type

label

Intraperitoneal delivery of hu ...... er in a mouse xenograft model.

@en

Intraperitoneal delivery of hu ...... er in a mouse xenograft model.

@nl

prefLabel

Intraperitoneal delivery of hu ...... er in a mouse xenograft model.

@en

Intraperitoneal delivery of hu ...... er in a mouse xenograft model.

@nl

P1433

Q37178190-07571A74-63C9-417A-85CF-7C602B20246C

P1476

Q37178190-E3203A27-945F-4C8E-836F-0D08EFE86220

P2093

Q37178190-07CCA7C2-7D3D-4034-89E1-7FD34142BA98

Q37178190-3BDCC213-49D4-484B-B2FB-5C17114F2BBD

Q37178190-ABC761E4-C1AB-4FBB-BEFA-17DBEE0C851C

Q37178190-BA0DCEEF-26F6-4157-8F47-5E863C7A0B2F

Q37178190-C0D1940B-F800-46A2-B54B-8A4413D63961

Q37178190-CA9FDD68-779C-41D3-942D-5962CF5D313B

P2860

Q37178190-03D5F215-4956-41A4-9B3A-72F32B02B6E6

Q37178190-0A84EC81-E9ED-4439-935A-83A155A7A787

Q37178190-1200341C-7B7D-498D-B906-354846D7EE67

Q37178190-32A01115-D971-4A48-9D86-C1B020632A44

Q37178190-35EF10E1-B573-4D97-ACFC-F2BA23277611

Q37178190-37FB6B20-2270-4D7F-B78F-FC28B6F766B9

Q37178190-3DB9D7E6-D5B8-49D9-A63C-C9E102DF3D69

Q37178190-52FB17E6-2BA4-4184-9280-708BF8BA15B0

Q37178190-65017A58-9612-4F1C-A83E-66E0378CD4E2

Q37178190-67CE22AE-D17D-467D-8000-C9B9BFE1B58A

P304

Q37178190-2C882F29-C783-4C9C-B175-1448EED2CF07

P31

Q37178190-E231941B-71FE-40C9-89AF-A34766C52719

P356

Q37178190-C9D7F063-6671-4499-9FD2-967CBD8C5D14

P433

Q37178190-DD29D9D9-56F3-45F8-86B2-9B3C4E2B3483

P478

Q37178190-CC903516-3885-4584-90BE-9E8A76492599

P50

Q37178190-33C27263-0C8B-4AD4-B77E-656D38EC9330

Q37178190-8083F752-27EB-4166-BC1F-4B102CC6B2FA

P577

Q37178190-2BD3B730-0F89-43F0-967C-57CDE809A981

P5875

Q37178190-DD509628-0511-42AF-945F-237009BD25C3

P698

Q37178190-03118397-7248-4F8A-AC01-484DFD454C1C

P921

Q37178190-3F272EEB-1A23-4440-A524-66644A95173D

Q37178190-E2441602-5280-4894-AADE-A3208A1E3FAF

P932

Q37178190-4D783A7E-F726-41EF-B91A-A024CE522A42

P356

J.JCYT.2013.05.022

P1433

P1476

Intraperitoneal delivery of hu ...... cer in a mouse xenograft model

@en

P2093

David A Hermanson

http://www.w3.org/2001/XMLSchema#string

David A Knorr

http://www.w3.org/2001/XMLSchema#string

Laura Bendzick

http://www.w3.org/2001/XMLSchema#string

Lee Pribyl

http://www.w3.org/2001/XMLSchema#string

Melissa A Geller

http://www.w3.org/2001/XMLSchema#string

Valarie McCullar

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-21 activates human natural killer cells and modulates their surface receptor expression

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells.

Memory-like responses of natural killer cells.

Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

P304

1297-1306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCYT.2013.05.022

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey S. Miller

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256329964

http://www.w3.org/2001/XMLSchema#string

P698

23993303

http://www.w3.org/2001/XMLSchema#string

P921

P932

3775496

http://www.w3.org/2001/XMLSchema#string